Reuters logo
BRIEF-EU recommends approval of Novo Nordisk's haemophilia drug
2017年3月24日 / 中午12点16分 / 8 个月前

BRIEF-EU recommends approval of Novo Nordisk's haemophilia drug

March 24 (Reuters) - EU Medicines Agency:

* EU Medicines Agency recommendations for March 2017

* Recommends approval of Novo Nordisk’s Nonacog Beta Pegol drug for treatment of haemophilia

* Recommends approval of Pfizer's Trumenba drug for prophylaxis against invasive meningococcal disease Link to press release: (bit.ly/2nv0UIk) Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below